Dr. Max Grogl

Dr. Max Grogl serves as a key technical and procurement lead at the Naval Medical Research Center, where he oversees the acquisition of advanced biomedical technologies critical to force health protection. His responsibilities include managing complex contracts for diagnostic systems, laboratory instrumentation, and field-deployable medical devices that support operational readiness in austere environments. Grogl plays a pivotal role in aligning procurement strategy with the Center’s mission to develop and validate rapid, precision-based medical solutions for Navy and Marine Corps personnel, ensuring acquisitions meet rigorous scientific and operational standards. His primary contractor relationship is with REES SCIENTIFIC CORPORATION, a trusted partner in the development and maintenance of specialized diagnostic and analytical equipment. Grogl consistently engages this vendor for high-precision instrumentation and laboratory support services, reflecting a pattern of long-term, technically demanding collaborations rather than transactional procurement. His contracting approach emphasizes technical fidelity, performance validation, and sustained support for mission-critical systems, fostering deep vendor engagement grounded in scientific expertise. Grogl’s procurement portfolio shows no preference for socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a mission-driven focus on technical capability over socioeconomic criteria, prioritizing the most qualified providers regardless of business size or certification status. While small business participation is not formally incentivized, vendors must still demonstrate proven competency in high-stakes medical diagnostics and laboratory environments. His primary NAICS focus areas include electronic and precision equipment repair and maintenance, in-vitro diagnostic substance manufacturing, analytical laboratory instrument manufacturing, testing laboratory services, and medical laboratory operations. These reflect a deep specialization in diagnostic innovation, point-of-care testing, and laboratory automation—domains essential to detecting emerging pathogens and ensuring medical readiness in deployed settings. Grogl’s expertise lies at the intersection of clinical science and acquisition, ensuring that procured systems meet both regulatory and operational demands of military medicine.